CD40 distribution and patterns of expression were further explored in larger cohorts of non-small cell lung cancer (NSCLC), ovarian cancer, and pancreatic adenocarcinoma, and correlated with clinicopathologic characteristics and outcome. The gene discussed is CD40; the disease is ovarian carcinoma.